Cargando…

P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT

Detalles Bibliográficos
Autores principales:	Jan Boelens, Jaap, Umair Mushtaq, Muhammad, Mcguirk, Joseph, Bauquet, Aurelie, Simons, Laura, Heimendinger, Pierre, Gaudeaux, Pierre, Andre, Isabelle, Paillet, Juliette, Negre, Olivier, Soheili, Tayebeh-Shabi, Oster, Sebastien, van den Brink, Marcel R.M., Lehmann, Frederic, Cavazzana, Marina, Perales, Miguel-Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430578/ http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c

Ejemplares similares

P1257: SMART101 DONOR T-LYMPHOID PROGENITORS TO ACCELERATE IMMUNE RECONSTITUTION POST-HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: SI101-02 PHASE I/II
por: Ciceri, Fabio, et al.
Publicado: (2023)

T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation
por: Gaudeaux, Pierre, et al.
Publicado: (2022)

101. Role of Allogeneic Placental Tissues in Penile Inversion Vaginoplasty
por: Satterwhite, Thomas, et al.
Publicado: (2023)

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
por: Morris, Emma C., et al.
Publicado: (2019)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers
por: Tsilifis, Christo, et al.
Publicado: (2023)

Multiple breath washout and oscillometry after allogenic HSCT: a scoping review
por: Sonneveld, Nicole, et al.
Publicado: (2023)

Measurements of the beta-decay energy of $^{101}$Rb, $^{101,102}$Sr and $^{101,102}$Y
por: Balog, K, et al.
Publicado: (1990)

101 Biomedical Prevention of HIV/AIDS in Russia
por: Karamov, E.V., et al.
Publicado: (2014)

A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain
por: Zhang, Shannon, et al.
Publicado: (2019)

Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
por: Mikhael, Neveen Lewis, et al.
Publicado: (2019)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Law 101 /
por: Feinman, Jay M.
Publicado: (2010)

101 Réikiavik
por: Helgason, Hallgrímur
Publicado: (2001)

Pollution 101
por: Spivey, A
Publicado: (2001)

Not Geropharmacotherapy 101
por: Finestone, Albert J, et al.
Publicado: (2007)

Investing 101
por: Kristof, Kathy
Publicado: (2008)

101 dálmatas /
Publicado: (1992)

Openstack 101
por: RODRIGUES MOREIRA, Belmiro
Publicado: (2014)

Mortgages 101
por: Reed, David
Publicado: (2018)

Conflict 101
por: SHEAROUSE, Susan
Publicado: (2011)

Teenagers 101
por: Deurlein, Rebecca
Publicado: (2014)

Coronavirus 101
por: Holstein, Barbara
Publicado: (2020)

Echonomics 101
por: Sorrell, Vincent L.
Publicado: (2023)

ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
por: Roy, Denis Claude, et al.
Publicado: (2020)

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Author Correction to: T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
por: Burns, D M, et al.
Publicado: (2016)

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
por: Redjoul, Rabah, et al.
Publicado: (2021)

Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT
por: Cao, Yigeng, et al.
Publicado: (2022)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
por: Redjoul, Rabah, et al.
Publicado: (2021)

P1426: WU-NK-101, AN ALLOGENEIC MEMORY NK CELL, FOR THE TREATMENT OF RELAPSE OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
por: Muth, J. J., et al.
Publicado: (2022)

101 sonetos : 1924-1975 /
por: Alberti, Rafael, 1902-1999
Publicado: (1980)

101 juegos : juegos no competitivos /
por: Guitart Aced, Rosa María
Publicado: (1998)

101 careers in mathematics
por: Haunsperger, Deanna, et al.
Publicado: (2019)

Magnet Quench 101
por: Bottura, L.
Publicado: (2014)

Creation & evolution 101
por: Bickel, Bruce, 1952-
Publicado: (2004)

101 quesos magistrales /
por: García del Cerro, Carlos
Publicado: (1992)

101 Design Methods
por: Kumar, Vijay
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ivd1viobkultpkiu0lupcqi5eq